Albert Reese - Mar 8, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Stock symbol
LEXX
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 04:32 PM
Previous filing
Jul 21, 2021
Next filing
May 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 917 Mar 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +3.4K +100% $0.00 6.8K Mar 8, 2022 Common Shares 3.4K $3.39 Direct
holding LEXX Stock Options 3.4K Mar 8, 2022 Common Shares 3.4K $4.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.